Does Singapore have the PCV20 vaccine and will it replace PCV13 as recommended in US? If it is available, why is it not subsidised?
While PCV20 was approved for use in Singapore in November 2022, it is not a vaccine recommended under the National Adult Immunisation Schedule (NAIS) currently.
Hence, it is not subsidised and MediSave cannot be used to cover the cost of this vaccine. You may wish to seek advice from your doctor on the use of PCV20 as an alternative to the PCV13 or PPSV23 vaccines. The Ministry of Health and the Expert Committee on Immunisation is assessing the clinical and cost effectiveness of PCV20 and how it should be used.
Need more help?
Get in touch